| |
| |
|
| Insider
Information: |
Gross Jeffrey M |
| Relationship: |
SVP, Research & Develo... |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Angiotech Pharmaceuticals Inc(USA) |
ANPIQ |
SVP, Research & Develo... |
2011-05-12 |
0 |
2009-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2011-05-12 |
4/A |
D |
$0.00 |
$0 |
D/D |
(51,000) |
0 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2010-03-26 |
4 |
D |
$1.11 |
$9,990 |
D/D |
(9,000) |
42,000 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2010-03-26 |
4 |
B |
$1.11 |
$9,990 |
D/D |
9,000 |
51,000 |
2.74 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-08-27 |
4 |
D |
$1.68 |
$10,080 |
D/D |
(6,000) |
36,000 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-08-27 |
4/A |
B |
$1.68 |
$10,080 |
D/D |
6,000 |
42,000 |
2.74 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-08-27 |
4 |
B |
$1.68 |
$10,080 |
D/D |
6,000 |
36,600 |
2.74 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-08-14 |
4 |
D |
$1.72 |
$2,580 |
D/D |
(1,500) |
34,500 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-08-13 |
4 |
D |
$1.80 |
$3,600 |
D/D |
(2,000) |
32,500 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research and Development |
• – – |
2009-06-22 |
4 |
B |
$1.77 |
$35,400 |
D/D |
20,000 |
32,500 |
2.74 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-06-22 |
4 |
D |
$1.77 |
$35,400 |
D/D |
(20,000) |
12,500 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-06-17 |
4 |
D |
$1.85 |
$23,125 |
D/D |
(12,500) |
0 |
0 |
- |
|
| ANPIQ |
Angiotech Pharmaceuticals... |
SVP, Research & Development |
• – – |
2009-06-17 |
4 |
B |
$1.85 |
$23,125 |
D/D |
12,500 |
12,500 |
2.74 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
